Samsung Bioepis Clears Up Second EU Bevacizumab Application

Market Entry Also Confirmed For Aybintio Biosimilar

Europe_Night
Samsung Bioepis' Onbevzi biosimilar has been backed for a Europe-wide MA • Source: Shutterstock

More from Biosimilars

More from Products